FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/01/022952 [Registered on: 27/01/2020] Trial Registered Prospectively
Last Modified On: 14/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   PHYTOESTROGEN RICH SUPPLEMENTATION ON MENSTRUAL IRREGULARITIES, PSYCHOLOGICAL STRESS AND PHYSICAL ACTIVITY LEVELS IN WOMEN WITH PCOS 
Scientific Title of Study   PHYTOESTROGEN RICH SUPPLEMENTATION ON MENSTRUAL IRREGULARITIES, PSYCHOLOGICAL STRESS AND PHYSICAL ACTIVITY LEVELS IN WOMEN WITH PCOS 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  K GAYATHRI 
Designation  Ph.D Research scholar 
Affiliation  Sri Ramachandra Institute of Higher Education and Research(DU) 
Address  Room no-20, Sathyalok Charitable trust, chettiyar agaram street, porur, chennai116
Department of Clinical Nutrition, Sri Ramachandra Institute of Institute of Higher Education and Research(DU), Porur, Chennai-116
Chennai
TAMIL NADU
600116
India 
Phone  9123567913  
Fax    
Email  gayathrikalidoss7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr V SUPRIYA 
Designation  Assistant professor 
Affiliation  Sri Ramachandra Institute of Higher Education and Research(DU) 
Address  Department of Clinical Nutrition, Sri Ramachandra Institute of Institute of Higher Education and Research(DU), Porur, Chennai-116

Chennai
TAMIL NADU
600116
India 
Phone  9841273715  
Fax    
Email  priiyas@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr V SUPRIYA 
Designation  Assistant professor 
Affiliation  Sri Ramachandra Institute of Higher Education and Research(DU) 
Address  Department of Clinical Nutrition, Sri Ramachandra Institute of Institute of Higher Education and Research(DU), Porur, Chennai-116

Chennai
TAMIL NADU
600116
India 
Phone  9841273715  
Fax    
Email  priiyas@gmail.com  
 
Source of Monetary or Material Support  
Not applicable 
 
Primary Sponsor  
Name  Founder Chancellor shri NPV Ramasamy udayar research fellowship 
Address  Sri Ramachandra Institution of Higher education and Research (Deemed to be university), chennai-116 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
K GAYATHRI  Obstetrics and Gynecology out patient unit(OP)  G-block Sri Ramachandra Medical Centre and Hospital, Department of Clinical Nutrition SRIHER(DU)
Chennai
TAMIL NADU 
9123567913

gayathrikalidoss7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E282||Polycystic ovarian syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dal mix powder  it gives for the treatment for PCOS. 30g of supplement (Dal mix powder) will be providedto interventional group for 60 days.  
Comparator Agent  Plain dal powder  it will be provided to the control group. Its not contain the phytoestrogen rich ingredients in it. Plain dal powder 30g/day will be provided to the control group for 60 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  pre menopausal and reproductive aged women 18-45 years, patients willing to give inform consent 
 
ExclusionCriteria 
Details  women with hysterectomy, cushing syndrome, hypo gonadisam and thyroid dysfunction 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
improvement in ovulation, decrease in blood glucose level and weight, reduced stress level  The Primary outcome will be measured after two months of supplementation period. The expected outcomes are improvement in ovulation, decrease in blood glucose level and weight, reduced stress level 
 
Secondary Outcome  
Outcome  TimePoints 
Reduced oxidative stress and reduced facial hair growth  reduction in oxidative stress 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   27/01/2020 
Date of Study Completion (India) 16/06/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Published two original research articles 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
The present study employed a unique approach by combining the phytoestrogen-rich ingredients and developed the phytoestrogen-rich supplement. Its potential impact among women with PCOS was analyzed. Results showed a potential decrease in depression, anxiety, and stress levels among the PCOS subjects. It accentuates that providing appropriate dietary counseling could have a potential impact in reducing LDL, free cholesterol, depression, anxiety, and stress levels in individuals with PCOS. It also reported an increase in HDL, FSH levels and improved the regulation of menstrual cycles among the subjects in the intervention group. Overall the study emphasized the statement that omega-3-fatty acid, polyphenols and flavonoids content in the phytoestrogen rich supplement had a positive impact in the management of PCOS. This highlights the need for longer-term studies to explore the extended benefits of the interventions and lifestyle changes proposed in the study 
Close